{
    "nct_id": "NCT03412812",
    "official_title": "A Phase I Dose Escalation Trial of Five Fraction Stereotactic Radiation Therapy for Brain",
    "inclusion_criteria": "* All patients must have histologically confirmed malignancy.\n* All patients must have imaging suggestive of one or more brain metastases.\n* Karnofsky performance status (KPS) â‰¥ 60\n* Age > 18 years\n* Patients must provide written informed consent to participate in the study.\n* Patients must have less than or equal to 10 brain metastases as identified on brain MRI.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of surgical resection to the tumor of interest\n* History of radiation to the tumor of interest\n* History of previous whole brain irradiation\n* Receipt of systemic therapy within one week of planned radiation treatment except for hormonal agents.\n* Patient is unable to have MRI or MRI contrast.\n* Inability to meet the appropriate normal tissue dose constraints secondary to tumor location should result in exclusion of the patient / tumor.\n* Patients with a non-index tumor (second tumor) greater than 3 cm in diameter will be excluded.",
    "miscellaneous_criteria": ""
}